Skip to main content
. Author manuscript; available in PMC: 2010 Oct 1.
Published in final edited form as: Respir Med. 2009 May 21;103(10):1448–1455. doi: 10.1016/j.rmed.2009.04.026

Figure 1.

Figure 1

Figure 1

Figure 1

Figure 1a: CT findings. Normal = no nodular bronchiectasis or cavitary disease; these subjects received on average, 5 months of treatment before enrollment at the NIH. Mild = nodular bronchiectasis limited to less than 3 lobes with no cavitary disease. Moderate = nodular bronchiectasis involving 3 or more lobes and/or cavitary disease limited to one lobe. Severe = multilobar cavitary disease regardless of presence or extent of nodular bronchiectasis. For the purposes of this categorization, the lingula was considered a separate lobe.

Figure 1b: Distribution of organism among persons with moderate\severe disease

Figure 1c. : Distribution of organism among persons with mild\moderate disease